These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12492446)

  • 1. Impact of genetic defects on coronary atherosclerosis in patients suspected of having familial hypercholesterolaemia.
    Descamps OS; Gilbeau JP; Luwaert R; Heller FR
    Eur J Clin Invest; 2003 Jan; 33(1):1-9. PubMed ID: 12492446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia.
    Descamps OS; Gilbeau JP; Leysen X; Van Leuven F; Heller FR
    Eur J Clin Invest; 2001 Nov; 31(11):958-65. PubMed ID: 11737238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia.
    Tada H; Kawashiri MA; Nohara A; Inazu A; Mabuchi H; Yamagishi M
    Eur Heart J; 2017 May; 38(20):1573-1579. PubMed ID: 28159968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia.
    Ibrahim S; Reeskamp LF; de Goeij JN; Hovingh GK; Planken RN; Bax WA; Min JK; Earls JP; Knaapen P; Wiegman A; Stroes ESG; Nurmohamed NS
    Eur J Prev Cardiol; 2024 May; 31(7):892-900. PubMed ID: 38243822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia.
    Vohl MC; Gaudet D; Moorjani S; Tremblay G; Perron P; Gagné C; Lesiège D; Bergeron J; Lupien PJ; Després JP
    Eur J Clin Invest; 1997 May; 27(5):366-73. PubMed ID: 9179542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis.
    Shin DG; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo JT; Hur SH; Jeong JO; Jang Y; Lee JH; Lee SH
    Atherosclerosis; 2015 Nov; 243(1):53-8. PubMed ID: 26343872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of familial hypercholesterolaemia in Western Australia.
    Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM
    Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study.
    Mangili LC; Miname MH; Silva PRS; Bittencourt MS; Rocha VZ; Mangili OC; Salgado Filho W; Chacra AP; Jannes CE; Pereira AC; Santos RD
    Atherosclerosis; 2017 Aug; 263():393-397. PubMed ID: 28499609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
    Heath KE; Gudnason V; Humphries SE; Seed M
    Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia.
    Alves AC; Etxebarria A; Soutar AK; Martin C; Bourbon M
    Hum Mol Genet; 2014 Apr; 23(7):1817-28. PubMed ID: 24234650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men.
    Gaudet D; Vohl MC; Couture P; Moorjani S; Tremblay G; Perron P; Gagné C; Després JP
    Atherosclerosis; 1999 Mar; 143(1):153-61. PubMed ID: 10208490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic risk score predicts coronary artery disease in familial hypercholesterolaemia: enhancing the precision of risk assessment.
    Ellis KL; Hooper AJ; Pang J; Chan DC; Burnett JR; Bell DA; Schultz CJ; Moses EK; Watts GF
    Clin Genet; 2020 Feb; 97(2):257-263. PubMed ID: 31571196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of familial hypercholesterolaemia in Morocco.
    El Messal M; Aït Chihab K; Chater R; Loutfi M; Kettani A; Hafidi A; Adlouni A
    Acta Cardiol; 2006 Oct; 61(5):551-5. PubMed ID: 17117756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans.
    Thompson GR
    Atherosclerosis; 2018 Sep; 276():148-154. PubMed ID: 30064057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypercholesterolaemia in a Belgian community.
    Descamps OS
    Acta Cardiol; 2000 Dec; 55(6):327-33. PubMed ID: 11227832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation.
    Ferrières J; Lambert J; Lussier-Cacan S; Davignon J
    Circulation; 1995 Aug; 92(3):290-5. PubMed ID: 7634440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of LDLR-negative genotype on CT coronary atherosclerosis in asymptomatic statin treated patients with heterozygous familial hypercholesterolemia.
    Ten Kate GJ; Neefjes LA; Dedic A; Nieman K; Langendonk JG; Galema-Boers AJ; Roeters van Lennep J; Moelker A; Krestin GP; Sijbrands EJ; de Feyter PJ
    Atherosclerosis; 2013 Apr; 227(2):334-41. PubMed ID: 23369702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.